Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Impaired Platelet Function in Ehlers-Danlos Syndrome: Insights from Human Subjects and a Murine Model

Mariia Kumskova, Gagan D. Flora, Manasa K. Nayak, Ivan Budnik, Madankumar Ghatge, Neelam Chauhan, Aditi Jain, Janice Staber, Steven R. Lentz, Anil K. Chauhan

Blood (2024) 144 (Supplement 1): 551.

https://doi.org/10.1182/blood-2024-204028

Published: 2024

Journal Articles

Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia

Eloy Roman, Bruno Fattizzo, Merrill Kingman Shum, Wahid T Hanna, Steven R Lentz, Sergio Schusterschitz S Araujo, Mohammed Al-Adhami, Federico V Grossi, Morie A Gertz

Blood blood.2023022549.

https://doi.org/10.1182/blood.2023022549

Published: 2024

Includes: Supplemental data

Journal Articles

Platelets from Ehlers-Danlos Syndrome Patients Exhibit Reduced GPVI Levels and Impaired Integrin αIIbβ3 inside-out Signaling

Mariia Kumskova, Gagan D. Flora, Manasa K. Nayak, Ivan Budnik, Aditi Jain, Rakeshkumar B. Patel, Steven R. Lentz, Anil K. Chauhan

Blood (2023) 142 (Supplement 1): 1191.

https://doi.org/10.1182/blood-2023-179466

Published: 2023

Journal Articles

Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study

Catherine Broome, David J Kuter, Keith R. McCrae, Rupert Davies, Amanda Enstrom, Allison Chunyk, Heather Thomas, Allison Naumovski, Steven R. Lentz

Blood (2023) 142 (Supplement 1): 5520.

https://doi.org/10.1182/blood-2023-179305

Published: 2023

Journal Articles

A Multiple Ascending Dose Study of Mim8 in Patients with Severe Hemophilia a with or without Factor VIII Inhibitors

Steven R. Lentz, Pratima Chowdary, Francisco Jose Lopez Jaime, Johnny Mahlangu, Irina Matytsina, Anne Louise Nielsen, Jerzy Windyga

Blood (2022) 140 (Supplement 1): 2735–2736.

https://doi.org/10.1182/blood-2022-160043

Published: 2022

Journal Articles

Longitudinal Efficacy and Safety of N8-GP for Prophylaxis and Bleed Control in US Patients

Allison P. Wheeler, Miguel A. Escobar, Susan Kearney, Janice M. Staber, Adam R. Wufsus, Vlady Ostrow, Steven R. Lentz

Blood (2021) 138 (Supplement 1): 3205.

https://doi.org/10.1182/blood-2021-147814

Published: 2021

Journal Articles

Cooling down VITT with IVIG

Steven R. Lentz

Blood (2021) 138 (11): 921–922.

https://doi.org/10.1182/blood.2021012819

Published: 2021

Journal Articles

The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis

Manasa K. Nayak, Madankumar Ghatge, Gagan D. Flora, Nirav Dhanesha, Manish Jain, Kathleen R. Markan, Matthew J. Potthoff, Steven R. Lentz, Anil K. Chauhan

Blood (2021) 137 (12): 1658–1668.

https://doi.org/10.1182/blood.2020007140

Published: 2021

Includes: Supplemental data

Journal Articles

COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19

Isaac Chambers, MD, Sanjana Dayal, PhD, Patrick Ten Eyck, PhD, Alicia Eustes, PhD, Grerk Sutamtewagul, MD, Lori Rosenstein, MD, Steven R Bailey, MDMSCAI, FACC, FACP, Steven R. Lentz, MDPhD, Usha Perepu, MBBS

Blood (2020) 136 (Supplement 1): 11.

https://doi.org/10.1182/blood-2020-141951

Published: 2020

Journal Articles

Role of Low Albumin Levels in Pediatric Patients with Central Venous Catheters at Risk for Thrombosis

Neha Bhasin, MD, Denise Roe, DrPH, Janna M. Journeycake, MD, Chelsea Large, Kathylynn Saboda, MS, Beth Boulden Warren, MD MS, Marilyn J Manco-Johnson, MD, David T. Harris, PhD, Michael Badowski, PhD, Lynn Gerald, Vivian Moreno, Steven R. Lentz, MD PhD

Blood (2019) 134 (Supplement_1): 3650.

https://doi.org/10.1182/blood-2019-124858

Published: 2019

Journal Articles

Consistency of Dosing of Turoctocog Alfa Pegol (N8-GP) throughout the Pathfinder Clinical Trials: Implications for Recommendations for Effective Prophylaxis, Bleed Resolution, and Perioperative Management

Miguel A. Escobar, MD, Allison P. Wheeler, MD, Steven R. Lentz, MD PhD, Wan Hui Ong Clausen, PhD, David Cooper

Blood (2019) 134 (Supplement_1): 3635.

https://doi.org/10.1182/blood-2019-124889

Published: 2019

Journal Articles

Targeting Metabolic Enzyme Pyruvate Kinase M2: A Novel Strategy to Inhibit Platelet Function and Arterial Thrombosis

Manasa K Nayak, PhD, Madankumar Ghatge, PhD, Nirav Dhanesha, PhD, Gagan D Flora, PhD, Manish Jain, PhD, Omar Rodriguez, MD BS, Kathleen Markan, PhD, Mathhhew Potthoff, PhD, Steven R. Lentz, MD PhD, Anil K Chauhan, PhD

Blood (2019) 134 (Supplement_1): 1056.

https://doi.org/10.1182/blood-2019-129027

Published: 2019

Journal Articles

Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism

Blood (2018) 132 (Supplement 1): 2506.

https://doi.org/10.1182/blood-2018-99-115529

Published: 2018

Journal Articles

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Sandra L Haberichter, PhD, Jorge Di Paola, MD, Paula D. James, MD, Janna M. Journeycake, MD, Steven R. Lentz, MD PhD, Cindy A. Leissinger, MD, Margaret V. Ragni, MD MPH, Madhvi Rajpurkar, MD, Jonathan C. Roberts, MD, Amy Shapiro, Robert F. Sidonio, Robert R Montgomery, MD, Thomas C. Abshire, MD

Blood (2018) 132 (Supplement 1): 979.

https://doi.org/10.1182/blood-2018-99-110650

Published: 2018

Journal Articles

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism

Clive Kearon, Sameer Parpia, Frederick A. Spencer, Trevor Baglin, Scott M. Stevens, Kenneth A. Bauer, Steven R. Lentz, Craig M. Kessler, James D. Douketis, Stephan Moll, Scott Kaatz, Sam Schulman, Jean M. Connors, Jeffrey S. Ginsberg, Luciana Spadafora, Vinai Bhagirath, Patricia C. Liaw, Jeffrey I. Weitz, Jim A. Julian

Blood (2018) 131 (19): 2151–2160.

https://doi.org/10.1182/blood-2017-09-805689

Published: 2018

Includes: Supplemental data

Journal Articles

On PAR with aPC to target inflammasomes

Steven R. Lentz

Blood (2017) 130 (24): 2579–2581.

https://doi.org/10.1182/blood-2017-09-806307

Published: 2017

Journal Articles

the NADPH Oxidase Catalytic Subunit Nox2 Displays Differential Roles in Arterial Vs. Venous Thrombosis

Vijay Sonkar, PhD, Melissa J Jensen, BS, Steven R. Lentz, MD PhD, Sanjana Dayal, PhD

Blood (2016) 128 (22): 4907.

https://doi.org/10.1182/blood.V128.22.4907.4907

Published: 2016

Journal Articles

Thrombosis in the setting of obesity or inflammatory bowel disease

Steven R. Lentz

Blood (2016) 128 (20): 2388–2394.

https://doi.org/10.1182/blood-2016-05-716720

Published: 2016

Journal Articles

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Blood (2016) 127 (20): 2481–2488.

https://doi.org/10.1182/blood-2015-10-673681

Published: 2016

Includes: Supplemental data

Journal Articles

Successful Use of rFVIII, Turoctocog Alfa, during Orthopedic and Nonorthopedic Surgery in Patients with Severe Hemophilia A

Luigi Solimeno, MD, Steven R. Lentz, MD PhD, Irina Matytsina, MD, Niels Zeuthen, Faraizah Abdul Karim, MD, Elena Santagostino, MD PhD

Blood (2015) 126 (23): 2304.

https://doi.org/10.1182/blood.V126.23.2304.2304

Published: 2015

NARROW

Impaired Platelet Function in Ehlers-Danlos Syndrome: Insights from Human Subjects and a Murine Model

Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia

Platelets from Ehlers-Danlos Syndrome Patients Exhibit Reduced GPVI Levels and Impaired Integrin αIIbβ3 inside-out Signaling

Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: The RUBY-4 Study

A Multiple Ascending Dose Study of Mim8 in Patients with Severe Hemophilia a with or without Factor VIII Inhibitors

Longitudinal Efficacy and Safety of N8-GP for Prophylaxis and Bleed Control in US Patients

Cooling down VITT with IVIG

The metabolic enzyme pyruvate kinase M2 regulates platelet function and arterial thrombosis

COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19

Role of Low Albumin Levels in Pediatric Patients with Central Venous Catheters at Risk for Thrombosis

Consistency of Dosing of Turoctocog Alfa Pegol (N8-GP) throughout the Pathfinder Clinical Trials: Implications for Recommendations for Effective Prophylaxis, Bleed Resolution, and Perioperative Management

Targeting Metabolic Enzyme Pyruvate Kinase M2: A Novel Strategy to Inhibit Platelet Function and Arterial Thrombosis

Whole Exome Sequencing and Extended Thrombophilia Testing in Patients with Venous Thromboembolism

Prospective Diagnosis of VWD in a Large Cohort of Patients with Bleeding Symptoms through the Zimmerman Program

Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism

On PAR with aPC to target inflammasomes

the NADPH Oxidase Catalytic Subunit Nox2 Displays Differential Roles in Arterial Vs. Venous Thrombosis

Thrombosis in the setting of obesity or inflammatory bowel disease

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Successful Use of rFVIII, Turoctocog Alfa, during Orthopedic and Nonorthopedic Surgery in Patients with Severe Hemophilia A

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only